Non invasive detection of vulnerable plaque 2
-
Upload
society-for-heart-attack-prevention-and-eradication -
Category
Health & Medicine
-
view
47 -
download
0
Transcript of Non invasive detection of vulnerable plaque 2
![Page 1: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/1.jpg)
Non-invasive Detection of Vulnerable Plaque using
SPIO Enhanced MRI
Mitra Rajabi MD, Maamoun AbouQamar MD, Michael Quast PhD, Jigna Wei MD, Daniel Chan PhD, Mohammad Madjid MD, Khawar Gul MD, Ponnada Narayana PhD, Ward Casscells MD, James Willerson MD,
Morteza Naghavi MD
Texas Heart InstituteThe University of Texas-Houston
![Page 2: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/2.jpg)
Everybody has atherosclerosis, the question is who has Vulnerable Plaque
![Page 3: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/3.jpg)
The Online Cardiovascular Research Community
www.VulnerablePlaque.org
All slides will be available on:
![Page 4: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/4.jpg)
![Page 5: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/5.jpg)
Vulnerable Plaque?Atherosclerotic plaques that cause sudden luminal clot formation and lead to heart attack and stroke.
![Page 6: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/6.jpg)
Different Types of Vulnerable Plaque As underlying Cause of Acute Coronary Events
NormalRupture-prone
Fissured ErodedCritical Stenosis Hemorrhage
![Page 7: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/7.jpg)
Rupture-prone inflamed plaque
Vulnerable Plaque Type 1
![Page 8: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/8.jpg)
Eroded Plaque with Exposed Proteoglycans Prone to Thrombosis
Vulnerable Plaque Type 2
![Page 9: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/9.jpg)
Fissured Plaque with Old and Fresh Overlaying Thrombi
Vulnerable Plaque Type 3
![Page 10: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/10.jpg)
Intra-Plaque Hemorrhage Prone to Thrombosis
Vulnerable Plaque Type 4
![Page 11: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/11.jpg)
Vulnerable Plaque Type 5
Asymptomatic significantly stenotic plaque prone to occlusion
![Page 12: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/12.jpg)
Further new types of Vulnerable Plaque to be
discovered in future.
![Page 13: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/13.jpg)
Less angiogenesis (?)Extensive angiogenesis
Low modified cholesterolHigh modified cholesterol
High collagen contentLow collagen content
Small or no lipid poolLarge lipid pool
Thick fibrous capThin fibrous cap
Low-Risk Plaque,Hard Plaque
Unstable Plaque, High-Risk Plaque, Soft Plaque
Structural or Morphologic ClassificationVulnerable Plaque Stable Plaque
![Page 14: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/14.jpg)
Not exposed but may contain as much
Exposed proteoglycans(versican and hyaluronan)
Intact endothelial lawyer Endothelial denudation
High collagen contentOverlaying thrombosis
No thrombosis Disrupted / fissured cap
Concentric (negative remodeling)
Eccentric (positive remodeling)
Small or large plaque volume
Small or large plaque volume
Structural or Morphologic ClassificationVulnerable Plaque Stable Plaque
Cont…
![Page 15: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/15.jpg)
Hemodynamically significant(>75% stenosis)
…
Hemodynamically insignificant(< 75% stenosis)
…
Low strain (stiff)High strain (elasticity) More calcifiedLess calcified ?
Structural or Morphologic ClassificationStable PlaqueVulnerable Plaque
Cont…
![Page 16: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/16.jpg)
Minimum apoptosis…
Excessive apoptosis …
Low oxidative stress High oxidative stress (excessive oxygen and nitrogen free radical formation)
Normal or high pH with minimum pH heterogeneity
Acidic with high pH heterogeneity
Normal temperature with minimal heterogeneity
Hot with increased temperature heterogeneity
Low traffic (monocyte and T cell recruitment)
High traffic (monocyte and T cell recruitment)
Quiescent PlaqueLow-Risk Plaque
Active PlaquesUnstable Plaque
High-Risk Plaque
Functional or Physiologic ClassificationVulnerable Plaque Stable Plaque
![Page 17: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/17.jpg)
Plaque characterization by MRI has been introduced by Toussaint and others to study structural properties of atherosclerotic plaque.
MRI and Plaque Characterization:
![Page 18: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/18.jpg)
Carotid artery plaqueCCA
Carotid bifurcation
ICA stenosis & plaque
Courtesy of
Dr. Chun Yuan University of Washington, Seattle
![Page 19: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/19.jpg)
Question! Lets assume that we are in our
dreamland and non-invasive MR imaging of coronary artery with <100 micron resolution is easily obtained, now the question is whether we are able to accurately detect all vulnerable plaques only by studying their structural properties or we need more?
![Page 20: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/20.jpg)
Plaque Morphology vs.
Plaque Activity
Why do we need to go beyond morphological assessment of plaques? Why do we need both?
The short answer is: because not all plaques with similar morphology would result in similar outcome.
![Page 21: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/21.jpg)
Functional vs. Structural Imaging
Inactive and non-inflamed plaque
Active and inflamed plaque
Different
Similar
IVUS OCT MRI w/o CM
Structural:
Functional: Thermography, Spectroscopy, MRI w/ CM
![Page 22: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/22.jpg)
Therefore,
We need a combined method to image both morphology and activity of plaques
![Page 23: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/23.jpg)
We need MRI with vulnerable plaque targeted contrast media that identifies:
1- Inflammation (macrophage infiltration),
2- Fissured/Permeable Cap, 3- Leaking Angiogenesis and
4- Intra-Plaque Hemorrhage
5- …
![Page 24: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/24.jpg)
Willerson et al:
Study of fluorescent labeled macrophage homing into Apo E deficient mice
Circ 1998
![Page 25: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/25.jpg)
SPIO Super Paramagnetic Iron Oxide
Colloidal coated nano-particles of iron oxide, e.g. dextran coated SPIO
20-100 nanometer particle size
Phagocyted by, and accumulated in cells with phagocytic activity Shortening MR relaxation time, early T2 and late T1 effect
![Page 26: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/26.jpg)
USPIO Ultra Super Paramagnetic Iron Oxide
Smaller particle size which yields a longer circulation time, yet less phagocytosis and more uptake by non-immune cells
![Page 27: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/27.jpg)
Particle Core Size Particle Size Blood (nm) (nm) Half-life
Combidex 5-6 20-30 8h
Feridex 4-6 35-50 2.4±0.2h
MION 4-6 17 varies
… … … ….
Examples of Commercially Available SPIO
![Page 28: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/28.jpg)
Prior works done by others for imaging inflammation by MRI and SPIO
![Page 29: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/29.jpg)
Maamoun add Ref
![Page 30: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/30.jpg)
Flash MR Image of a Rat Kidney With Experimental Nephritic Syndrome, Before (Right)and 24h After USPIO Injection(left)
Maamoun add Ref
![Page 31: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/31.jpg)
Correlation between macrophage and MR signal reduction in the kidney cortex
Maamoun add Ref
![Page 32: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/32.jpg)
Cardiac Application Monitoring rejection of transplanted
heart and lungs following rat allograft and homograft transplantation, w/wo cyclosporin
Ho et al, ISMRM 2000
![Page 33: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/33.jpg)
Old literature!
Iron particles observed immediately under the endothelium 5 hours after the administration, in artery, in a rat with 7 days hypertension
33 years ago !!!
Gordon et al, 1968
Maamoun add Ref
![Page 34: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/34.jpg)
Our Hypothesis: Vulnerable atherosclerotic plaques
which have 1) active recruitment of monocytes and T cells, 2) extensive leaking angiogenesis 3) fissured or permeable cap can be detected by excessive uptake of SPIO particles.
![Page 35: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/35.jpg)
vasa vasorum
Over magnification is a major advantage of SPIO
Darkening property of SPIO in the white background of fat and water of plaque is another advantage
![Page 36: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/36.jpg)
Why negative enhancement?!!
Positive Contrast Negative ContrastV.S.
Gd-compounds SPIOs
+ -Knowing that plaque has white background due to its fat and water
![Page 37: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/37.jpg)
What we have done: - In vitro study of SPIO uptake by
macrophages using fluorescent labeled home-made SPIO
-In vitro study of SPIO uptake by macrophages and its effect on T2 relaxation time
-In vitro study of effect of SPIO on macrophage biology and super oxide production
![Page 38: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/38.jpg)
What we have done: - In vivo study of bio distribution of
SPIO in Apo E deficient atherosclerotic mice vs normal wild type C57 black mice
In vivo MRI study of aortic wall in Apo E deficient mice vs. wild type normal mice 4.7 T -in collaboration with Dr Quast’s lab UTMB
![Page 39: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/39.jpg)
Invitro Study of Macrophage SPIO Uptake In a series of invitro studies we
have tested the rate of SPIO uptake by human activated monocytes in different conditions regarding incubation time and concentration of SPIO. All SPIO were labeled by a fluorescent dye (DCFA)
![Page 40: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/40.jpg)
FL-labeled SPIO Incubated Macrophages 24hr
![Page 41: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/41.jpg)
Mouse Peritoneal Macrophages Incubated with SPIO after 6hr
![Page 42: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/42.jpg)
Double DAPI Staining with Fluorescence-labeled SPIO Macrophages after 24hr Incubation
![Page 43: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/43.jpg)
![Page 44: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/44.jpg)
SPIO and T2 Effect Invitro study to show the effect of macrophage SPIO uptake on their T2 relaxation time
![Page 45: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/45.jpg)
Protocol: We used 8 flasks of CBM macrophages. After preparing the cells, Feridex was
added with the proper concentration to each labeled tube.
Incubation was done at 37 C. For each time, pellet the tubes at 1000
rpm’s for 5 min. Washed with 1X PBS for 5 min 3 times. Resuspended in 2% paraformaldehyde, to
fix the cells.
![Page 46: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/46.jpg)
time
concentration
20 Min
1 Hour
6 Hours
24 Hours
50µl 100µl 250µl 500µl control control
Expected T2 Reduction Effect
![Page 47: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/47.jpg)
![Page 48: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/48.jpg)
![Page 49: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/49.jpg)
Macrophage Uptake of Feridex After 20 Min Shown by T2 Reduction
0102030405060708090
50 100 250 500 control control
20 min
Concentration µl
![Page 50: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/50.jpg)
0102030405060708090
50 100 250 500 control control
60 min
Macrophage Uptake of Feridex After 60 Min Shown by T2 Reduction
Concentration µl
![Page 51: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/51.jpg)
0102030405060708090
50 100 250 500 control control
6 Hours
Macrophage Uptake of Feridex After 6hr Shown by T2 Reduction
Concentration µl
![Page 52: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/52.jpg)
0102030405060708090
50 100 250 500 control control
24 Hours
Macrophage Uptake of Feridex After 24hr Shown by T2 Reduction
Concentration µl
![Page 53: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/53.jpg)
0102030405060708090
50 100 250 500 control control
20 min60 min6 hours24 hours
Macrophage Uptake of Feridex with Time and Concentration Shown by T2 Reduction
Concentration µl
![Page 54: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/54.jpg)
0102030405060708090
20 Min 60 Min 6 Hours 24 Hours
50100250500controlcontrol
Macrophage Uptake of Feridex with Concentration and Time Shown by T2 Reduction
µl
![Page 55: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/55.jpg)
Study of production of Reactive Oxygen Species by SPIO Incubated Macrophages
![Page 56: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/56.jpg)
Since the production of reactive oxygen species (ROS) in the plaque might have unfavorable effects on the biology of the plaque, we have planned to check if the SPIO would excessively produce ROS.
![Page 57: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/57.jpg)
Facts Any event of phagocytosis is immediately followed by
a transient release of super oxide due to the assembly of the NADPH oxidase against the plasma membrane. Subsequently the oxidase translocates onto the phagosomes containing the SPIO to produce intracellular ROS.
Thus an early extra cellular secretion of super oxide is detectable (using luminol) soon after phagocytosis and a later event of intracellular secretion is measurable using DCFDA dye .
![Page 58: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/58.jpg)
Method · The suspension of SPIO (1.25-10 uL) was added to
macrophages (1x10*4/well in 96 well plates). Cells were incubated for 1 h and washed to remove extra cellular FDIO. For each dose three wells were tested.
Isoluminol substrate was added and super oxide induced luminescence measured at 15, 30 and 45 min intervals using a luminometer.
![Page 59: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/59.jpg)
Results
· SPIO was internalized by macrophages as early as 15 min after addition.
· Uptake was followed by release of super oxide for all four doses tested.
Super oxide was released by SPIO at all doses tested (1.25-10 ul)
![Page 60: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/60.jpg)
Dosage of SPIO: 1.25micL
0
500
1000
1500
2000
2500
3000
3500
15min 30min 45min NOSPIO
Sample1Sample2Sample3
ROS Production: Time VS SPIO Concentration
![Page 61: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/61.jpg)
Dosage at 2.5micL
0
500
1000
1500
2000
2500
3000
3500
15min 30min 45min
Sample1Sample2Sample3
ROS Production: Time VS SPIO Concentration
![Page 62: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/62.jpg)
Dosage at 5micL
0
500
1000
1500
2000
2500
3000
15min 30min 45min
Sample1Sample2Sample3
ROS Production: Time VS SPIO Concentration
![Page 63: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/63.jpg)
Dosage at 10micL
0200400600800
10001200140016001800
15min 30min 45min
Sample1Sample2Sample3
ROS Production: Time VS SPIO Concentration
![Page 64: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/64.jpg)
SPIO biodistribution in ApoE mice
![Page 65: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/65.jpg)
Iron staining of mouse circulating monocyte after 15 minutes
![Page 66: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/66.jpg)
Iron staining of mouse circulating monocyte after 30 minutes
![Page 67: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/67.jpg)
Specimens were taken at interval of 3mm from arotic root to the renal aorta
![Page 68: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/68.jpg)
SPIO Accumulation in Atherosclerotic Plaque
Atherosclerotic plaque in aortic root
Normal aortic segment
Iron staining of Apo E K/O Aorta, 24 hour after SPIO injection
Iron
particles
![Page 69: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/69.jpg)
ApoE Mouse 3 Days After Injection
H&E Pearl’s
Aorta-2
Atherosclerotic plaque in thoracic aorta
![Page 70: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/70.jpg)
Aortic Root after 5 days
Dense infiltration of iron particles as shown by light blue in Pearl’s staining
![Page 71: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/71.jpg)
Aortic Plaque at Renal Level After 3 days
![Page 72: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/72.jpg)
![Page 73: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/73.jpg)
![Page 74: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/74.jpg)
![Page 75: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/75.jpg)
![Page 76: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/76.jpg)
Control C57BlackNo plaque, No Iron
Pearl’s staining
![Page 77: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/77.jpg)
0
5
10
15
AtheroscleroticAorta
Averagenumber of ironparticles persample
P <0.001
Comparison of the Number of the Iron Particles in Apo E KO Mice Plaque vs. Normal Wall
Normal-Looking
Vessel Wall of Same Apo E Mice
![Page 78: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/78.jpg)
MRI SPIO study of Apo E v.s. Normal Mice
![Page 79: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/79.jpg)
![Page 80: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/80.jpg)
![Page 81: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/81.jpg)
TE: 12ms TR: 2500 FOV: 6x6
256x256
Only respiratory gating was done
![Page 82: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/82.jpg)
Images of aorta from renal level
![Page 83: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/83.jpg)
MR Image of Abdominal Aorta After SPIO Injection in Apo E and Control Mice
Apo E deficient mouse
C57B1 (control) mouse
Before Injection After Injection (5 Days )
Dark (negatively enhanced) aortic wall, full of iron particles
Bright aortic lumen and wall without negative enhancement and no significant number of iron particles in pathology
![Page 84: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/84.jpg)
MRI Imaging of Atherosclerosis using SPIO
Studies done recently by others:
1- Schmitz SA, Coupland SE, Gust R, Winterhalter S, Wagner S, Kresse M, Semmler W, Wolf KJ
Superparamagnetic iron oxide-enhanced MRI of atherosclerotic plaques in Watanabe hereditable hyperlipidemic rabbits.Invest Radiol. 2000 Aug;35(8):460-71.
![Page 85: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/85.jpg)
Group I II III IV
USPIO 0 50µmol Fe/kg 50µmol 200µmol
Time - 8 hr 24 hr 48 hr
Schmitz et al J. Inv. Radiol. 2000
![Page 86: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/86.jpg)
Control
SPIO Injected
Schmitz et al J. Inv. Radiol. 2000
![Page 87: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/87.jpg)
Schmitz et al J. Inv. Radiol. 2000
![Page 88: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/88.jpg)
Schmitz et al
J. Inv. Radiol. 2000
![Page 89: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/89.jpg)
![Page 90: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/90.jpg)
Schmitz et al J. Inv. Radiol. 2000
![Page 91: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/91.jpg)
2- Ruehm SG, Corot C, Vogt P, Kolb S, Debatin JF.
Magnetic resonance imaging of atherosclerotic plaque with ultrasmall superparamagnetic particles of iron oxide in hyperlipidemic rabbits.
Circulation. 2001 Jan 23;103(3):415-22.
Studies done recently by others:
MRI Imaging of Atherosclerosis using SPIO
![Page 92: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/92.jpg)
A, Coronal MIP and (B) sagittal oblique and (C) coronal oblique reformatted images of contrast-enhanced 3D MRA data set collected after intravenous administration of Gd-DOTA displaying aorta of 7-month-old hyperlipidemic rabbit. Aortic wall is smooth, without evidence of luminal narrowing.
Reuhm et al,
Circulation
2001
![Page 93: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/93.jpg)
A, Coronal MIP and (B) sagittal oblique and (C) coronal oblique reformatted images of contrast-enhanced 3D MRA data sets of same hyperlipidemic rabbit as depicted in Figure 1 obtained 5 days after intravenous injection of USPIO agent Sinerem. Note susceptibility effects originating within vessel wall and representing Fe uptake in macrophages embedded in plaque.
Reuhm et al,
Circulation
2001
![Page 94: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/94.jpg)
A, Intraluminal signal measured in single large ROI (9 mm2) revealed significant increase in SNR, with maximum reached at day 5 after contrast administration. These changes reflect T2* effects, which decreased over time. B, SNR values based on 3 ROI measurements in aortic wall of each animal failed to reveal statistical difference between precontrast and 5 days post-Sinerem image sets in normal control rabbits. In hyperlipidemic animals, conversely, significant decrease in SNR corresponding to select USPIO uptake in plaque formations containing MPS cells was evident.
Reuhm et al, Circulation 2001
![Page 95: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/95.jpg)
Ex vivo imaging of contrast-filled aortic specimen of (A) hyperlipidemic rabbit 5 days after administration of Sinerem, (B) normal control rabbit 5 days after administration of Sinerem, and (C) hyperlipidemic rabbit that did not receive Sinerem. Marked susceptibility artifacts are present in aortic wall of hyperlipidemic rabbit that had received Sinerem (A). No such changes are visualized in other 2 rabbits (B, C).
Reuhm et al,
Circulation
2001
![Page 96: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/96.jpg)
Cross-sectional histopathological sections with Prussian blue staining of aorta of same hyperlipidemic rabbit as depicted in Figures 1 and 3, killed 5 days after administration of USPIO agent Sinerem. Note thickening of intima with marked staining of Fe particles embedded in atherosclerotic plaque formations.
Rheum et al,
Circulation
2001
![Page 97: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/97.jpg)
Conclusion: Non-invasive MRI study of
atherosclerotic plaques using SPIO (pre and post injection comparison) may be a likely method for detection of vulnerable plaques
Further studies particularly human clinical trials are warranted
![Page 98: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/98.jpg)
SPIO Clinical Trial:- The first human clinical trial on
detection of carotid vulnerable plaque using SPIO in patients undergoing carotid endartherectomy
Baseline
Scan
SPIO Injection
1hr post-injection
5days
Scan
Surgery
![Page 99: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/99.jpg)
Dr. Naghavi – The first volunteer subject in his Carotid MRI SPIO Study
![Page 100: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/100.jpg)
![Page 101: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/101.jpg)
![Page 102: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/102.jpg)
![Page 103: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/103.jpg)
![Page 104: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/104.jpg)
Multi-Center Trial: The second site of the study is
going to be Univ. of Washington Seattle directed by Dr. Yuan.
The interim report of the trial will be presented at AHA 2001 in Anaheim
![Page 105: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/105.jpg)
The Online Cardiovascular Research Community
www.VulnerablePlaque.org
All slides will be available on:
![Page 106: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/106.jpg)
![Page 107: Non invasive detection of vulnerable plaque 2](https://reader036.fdocuments.us/reader036/viewer/2022070523/58ecc6c31a28abec2c8b46b9/html5/thumbnails/107.jpg)
WWW.HotPlaque.Com